Detail akcie PainReform Rg online

Business Summary: PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Financial Summary: BRIEF: For the six months ended 30 June 2025, PainReform Ltd revenues was not reported. Net loss decreased 82% to $2.3M. Lower net loss reflects Research and development expenses decrease of 98% to $278K (expense), Exchange rate differences increase from $3K to $8K (income), Bank fees decrease of 44% to $5K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$93.51 to -$1.09.